Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
Authors:
Open Access
- 28 February 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 32, 36-47
Abstract
No abstract availableKeywords
Funding Information
- State University of New York
- National Science Foundation (DBI 0923133)
- National Institutes of Health (1R01EB019411-01A1)
- National Institute of Biomedical Imaging and Bioengineering
This publication has 51 references indexed in Scilit:
- The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cellsRespiratory Research, 2013
- miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/ -catenin pathwayNucleic Acids Research, 2013
- miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in MiceMolecular Therapy, 2012
- Participation of miR-200 in Pulmonary FibrosisThe American Journal of Pathology, 2012
- Smad3-Mediated Upregulation of miR-21 Promotes Renal FibrosisJournal of the American Society of Nephrology, 2011
- miR-192 Mediates TGF-β/Smad3-Driven Renal FibrosisJournal of the American Society of Nephrology, 2010
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosisJournal of Experimental Medicine, 2010
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating CellsPLOS ONE, 2009
- Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal InteractionsPLOS ONE, 2009
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences of the United States of America, 2008